3F-NEB
Appearance
From Wikipedia, the free encyclopedia
Substituted cathinone stimulant drug
![]() | |
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H16FNO |
Molar mass | 209.264 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Fluoro-N-ethylbuphedrone (3F-NEB) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It was first identified in Sweden in 2021.[1][2]
See also
[edit]
References
[edit]- ^ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 2024-03-10). ISBN 978-92-9497-737-3.
{{cite book}}
: CS1 maint: DOI inactive as of March 2024 (link) - ^ Kuropka P, Zawadzki M, Szpot P (September 2022). "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology. 41 (1): 25–46. doi:10.1007/s11419-022-00639-5. PMC 9476408. PMID 36124107.
Retrieved from "https://wiki.riteme.site/w/index.php?title=3F-NEB&oldid=1213028701"
Hidden categories:
- CS1 maint: DOI inactive as of March 2024
- Articles with short description
- Short description is different from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes